News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Hagop Kantarjian: Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangements
Photo of Dr. Hagop Kantarjian from obroncology.com
May 15, 2025, 13:36

Hagop Kantarjian: Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangements

Hagop Kantarjian, Associate Vice President for Global Academic Programs at MD Anderson Cancer Center, shared on X a recent paper published in Leukemia Journal:

“New in Leukemia Journal: Outcomes in intensively treated KMT2Ar AML have improved over time. But low-intensity therapies still show poor results — highlighting the urgent need to explore menin inhibitors.”

Title: Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangements

Authors: Alex Bataller, Hannah E. Goulart, Ghayas C. Issa, Courtney D. DiNardo, Naval Daver, Tapan Kadia, Alexandre Bazinet, Ian M. Bouligny, Jayastu Senapati, Fadi G. Haddad, Gautam Borthakur, Koji Sasaki, Nicholas J. Short, Musa Yilmaz, Guillermo Montalban-Bravo, Guiling Tang, Sanam Loghavi, Guillermo Garcia-Manero, Farhad Ravandi, Hagop Kantarjian and Elias Jabbour.

Hagop Kantarjian: Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangements

Read more about the article.

Find more posts on OncoDaily.

Alex Bataller Alexandre Bazinet cancer Courtney D. DiNardo Elias Jabbour Fadi G. Haddad Farhad Ravandi Gautam Borthakur Ghayas C. Issa Guiling Tang Guillermo Garcia-Manero Guillermo Montalban-Bravo Hagop Kantarjian Hannah E. Goulart Ian M. Bouligny Jayastu Senapati Koji Sasaki Musa Yilmaz Naval Daver Nicholas J. Short OncoDaily Oncology Sanam Loghavi Tapan Kadia
Special Coverage
Oncolibrary
May 15, 2025, 13:36
EMBER-3 Trial Updates from ESMO Breast 2025: Imlunestrant Plus Abemaciclib Improves PFS in CDK4/6i-Pretreated ER+/HER2- Breast Cancer
Science
May 15, 2025, 13:36
Hagop Kantarjian: Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangements
Blog
May 15, 2025, 13:30
The Pivotal Role of Cancer Nurses in Shaping the Future of Oncology Care - European Oncology Nursing Society
Blog
May 15, 2025, 13:22
UICC President Ulrika Årehed Kågström Welcomed participants to the 1st Cancer Planners Forum
Blog
May 15, 2025, 13:18
Three AACR25 Sessions Featured the First Disclosures of 12 New Cancer Therapeutics
Blog
May 15, 2025, 12:59
Learn More about MRD and How it can Impact You and Your Treatment - Fight Colorectal Cancer
Blog
May 15, 2025, 12:46
City Cancer Challenge and Access Accelerated will host a high-level side event at the 78th World Health Assembly
Blog
May 15, 2025, 12:43
The Role of IHC Expanding the List of Potential Targets - Caris Life Sciences
Blog
May 15, 2025, 12:43
Alex Kirby: Week 4 of the Pioneer Group Accelerator Programme
Radiotherapy
May 15, 2025, 12:30
Radiotherapy For Soft Tissue Sarcomas: Types, Success Rate, Side Effects And More
Blog
May 15, 2025, 12:18
UT MD Anderson and Texas Children's Hospital Launch Kinder Children's Cancer Center with $150 million gift
Oncolibrary
May 15, 2025, 11:58
Neurological Side Effects of Chemotherapy